Renal Function During Laparoscopic Surgery
Information source: Catholic University of the Sacred Heart
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Intra Operative Fluid Management
Intervention: Dopamine (Drug)
Phase: N/A
Status: Completed
Sponsored by: Catholic University of the Sacred Heart
Summary
Aim of this study was to investigate the cardiac and renal responses to the administration
of different amount of crystalloids, with and without dopamine, during gynaecological
laparoscopic surgery.
Clinical Details
Official title: Dopamine Infusion and Crystalloids Administration Improve Renal Function During Laparoscopic Surgery
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Primary outcome: estimated glomerular filtration rate, tissue Doppler imaging, E/Ea
Secondary outcome: total intra operative diuresis (TID)
Eligibility
Minimum age: 24 Years.
Maximum age: 42 Years.
Gender(s): Female.
Criteria:
Inclusion Criteria:
- ASA I
- age 24-42
- patients undergoing gynaecological laparoscopy
Exclusion Criteria:
- cardiovascular diseases
- renal and endocrine disorders
- obesity (BMI > 30 Kg/m2)
- the assumption of drugs that could interfere with renal parameters considered in the
study
Locations and Contacts
Catholic University of the sacred Heart, Rome 00168, Italy
Additional Information
Starting date: March 2012
Last updated: November 5, 2012
|